Availability of anti-rabies vaccine and rabies immunoglobulin in Indian health facilities: a nationwide cross-sectional health facility survey

IF 6.2 Q1 HEALTH CARE SCIENCES & SERVICES
Navaneeth S. Krishna , Jeromie Wesley Vivian Thangaraj , Shanmugasundaram Devika , Aruna Sasi , Suganya Egambaram , D Sudha Rani , Siraj Ahmed Khan , Anitha Delli , Ashok Kumar Srivastava , Ayush Mishra , Basavaraj Shrinivasa , Chandhini Pandiyan , Devendra Gour , Debjani Ram Purakayastha , Nirmal Verma , Parul Sharma , Ravinder Kumar Soni , Sabarinatha Ramasamy , Sreelakshmi Mohandas K , Subrata Baidya , Manoj V. Murhekar
{"title":"Availability of anti-rabies vaccine and rabies immunoglobulin in Indian health facilities: a nationwide cross-sectional health facility survey","authors":"Navaneeth S. Krishna ,&nbsp;Jeromie Wesley Vivian Thangaraj ,&nbsp;Shanmugasundaram Devika ,&nbsp;Aruna Sasi ,&nbsp;Suganya Egambaram ,&nbsp;D Sudha Rani ,&nbsp;Siraj Ahmed Khan ,&nbsp;Anitha Delli ,&nbsp;Ashok Kumar Srivastava ,&nbsp;Ayush Mishra ,&nbsp;Basavaraj Shrinivasa ,&nbsp;Chandhini Pandiyan ,&nbsp;Devendra Gour ,&nbsp;Debjani Ram Purakayastha ,&nbsp;Nirmal Verma ,&nbsp;Parul Sharma ,&nbsp;Ravinder Kumar Soni ,&nbsp;Sabarinatha Ramasamy ,&nbsp;Sreelakshmi Mohandas K ,&nbsp;Subrata Baidya ,&nbsp;Manoj V. Murhekar","doi":"10.1016/j.lansea.2025.100608","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Ensuring the uninterrupted availability of the anti-rabies vaccine (ARV) and rabies immunoglobulin (RIG) in health facilities is crucial to achieve the global target of zero dog-mediated human rabies deaths by 2030. This study aimed to estimate the availability of ARV and RIG across health facilities in India.</div></div><div><h3>Methods</h3><div>We conducted a nationwide health facility-based, cross-sectional study across 60 districts selected by multistage probability sampling from 15 Indian states. In each district, we selected nine health facilities. We interviewed staff involved in the rabies control program in each of the selected health facilities, and abstracted and physically validated information on the availability of ARV and RIG.</div></div><div><h3>Findings</h3><div>Of the 534 health facilities surveyed, 467 (87.5%) were public sector health facilities. ARV was available in 372 (79.7%, 95% CI: 75.7%–83.2%) public sector health facilities, ranging from 60.0% to 93.2% in different geographic regions. Availability of ARV was lowest in Urban Primary Healthcare Centres (UPHCs) (58.9%, 95% CI: 45.0%–71.9%). RIG was available in 95 (20.3%, 95% CI: 16.8%–24.3%) public sector health facilities, with the highest availability in southern states (27/88, 30.7%). The availability of RIG ranged from 1.8% (95% CI: 16.8%–24.3%) in UPHCs to 69.2% (95% CI: 48.2%–85.7%) in medical college hospitals.</div></div><div><h3>Interpretation</h3><div>Considerable geographic and facility-level variations exist in the availability of ARV and RIG across India. Bridging the gap in the availability of ARV and RIG should be prioritised to achieve the goal of zero-dog-mediated human rabies deaths by 2030.</div></div><div><h3>Funding</h3><div><span>Indian Council of Medical Research</span>.</div></div>","PeriodicalId":75136,"journal":{"name":"The Lancet regional health. Southeast Asia","volume":"38 ","pages":"Article 100608"},"PeriodicalIF":6.2000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Lancet regional health. Southeast Asia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772368225000794","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Ensuring the uninterrupted availability of the anti-rabies vaccine (ARV) and rabies immunoglobulin (RIG) in health facilities is crucial to achieve the global target of zero dog-mediated human rabies deaths by 2030. This study aimed to estimate the availability of ARV and RIG across health facilities in India.

Methods

We conducted a nationwide health facility-based, cross-sectional study across 60 districts selected by multistage probability sampling from 15 Indian states. In each district, we selected nine health facilities. We interviewed staff involved in the rabies control program in each of the selected health facilities, and abstracted and physically validated information on the availability of ARV and RIG.

Findings

Of the 534 health facilities surveyed, 467 (87.5%) were public sector health facilities. ARV was available in 372 (79.7%, 95% CI: 75.7%–83.2%) public sector health facilities, ranging from 60.0% to 93.2% in different geographic regions. Availability of ARV was lowest in Urban Primary Healthcare Centres (UPHCs) (58.9%, 95% CI: 45.0%–71.9%). RIG was available in 95 (20.3%, 95% CI: 16.8%–24.3%) public sector health facilities, with the highest availability in southern states (27/88, 30.7%). The availability of RIG ranged from 1.8% (95% CI: 16.8%–24.3%) in UPHCs to 69.2% (95% CI: 48.2%–85.7%) in medical college hospitals.

Interpretation

Considerable geographic and facility-level variations exist in the availability of ARV and RIG across India. Bridging the gap in the availability of ARV and RIG should be prioritised to achieve the goal of zero-dog-mediated human rabies deaths by 2030.

Funding

Indian Council of Medical Research.
印度卫生机构抗狂犬病疫苗和狂犬病免疫球蛋白的供应情况:一项全国卫生机构横断面调查
背景:确保卫生机构不间断地提供抗狂犬病疫苗和狂犬病免疫球蛋白,对于实现到2030年实现狗介导的人类狂犬病零死亡的全球目标至关重要。这项研究旨在估计印度各卫生机构抗逆转录病毒药物和RIG的可用性。方法我们在印度15个邦通过多阶段概率抽样选择的60个地区开展了一项以全国卫生机构为基础的横断面研究。在每个地区,我们选择了9个卫生设施。我们采访了每个选定的卫生机构中参与狂犬病控制规划的工作人员,提取并实际验证了ARV和RIG可用性的信息。在调查的534个卫生设施中,467个(87.5%)是公共部门卫生设施。372家(79.7%,95%可信区间:75.7%-83.2%)公共部门卫生设施提供抗逆转录病毒药物,在不同地理区域从60.0%到93.2%不等。城市初级保健中心(uphc)抗逆转录病毒药物的可得性最低(58.9%,95%可信区间:45.0%-71.9%)。95家(20.3%,95%可信区间:16.8%-24.3%)公共部门卫生设施提供了RIG,其中南部各州的可获得性最高(27/88,30.7%)。RIG的可得性从高保健医院的1.8% (95% CI: 16.8%-24.3%)到医学院医院的69.2% (95% CI: 48.2%-85.7%)不等。在印度各地,ARV和RIG的可用性存在着相当大的地理和设施水平差异。应优先缩小抗逆转录病毒药物和RIG供应方面的差距,以实现到2030年实现狗介导的人类狂犬病零死亡的目标。资助印度医学研究委员会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信